|
TM2D1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.57439999998377E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.77130000000348E-05 |
| Normal-vs-Stage2 |
1.201150E-03 |
| Normal-vs-Stage3 |
8.43209999999983E-05 |
| Normal-vs-Stage4 |
4.457500E-02 |
| Stage1-vs-Stage2 |
7.805800E-01 |
| Stage1-vs-Stage3 |
5.227800E-01 |
| Stage1-vs-Stage4 |
7.105800E-01 |
| Stage2-vs-Stage3 |
7.893800E-01 |
| Stage2-vs-Stage4 |
5.947400E-01 |
| Stage3-vs-Stage4 |
4.194400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1827999999946E-05 |
| Normal-vs-AfricanAmerican |
2.43540000000042E-05 |
| Normal-vs-Asian |
1.546990E-01 |
| Caucasian-vs-AfricanAmerican |
3.384400E-01 |
| Caucasian-vs-Asian |
6.732600E-01 |
| AfricanAmerican-vs-Asian |
4.714000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.59360000032238E-07 |
| Normal-vs-Female |
8.400500E-03 |
| Male-vs-Female |
7.335700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.560880E-03 |
| Normal-vs-Extreme_Weight |
1.57590000005037E-06 |
| Normal-vs-Obese |
4.51779999999236E-06 |
| Normal-vs-Extreme_Obese |
4.157300E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.620560E-01 |
| Normal_Weight-vs-Obese |
2.361600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.377000E-01 |
| Extreme_Weight-vs-Obese |
8.356800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.129800E-01 |
| Obese-vs-Extreme_Obese |
7.297800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.116100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.45590000000196E-05 |
| Normal-vs-Age(61-80Yrs) |
1.93738999999526E-05 |
| Normal-vs-Age(81-100Yrs) |
9.796200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.862000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.561200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.899810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.774800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.388400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.360200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.66299999995834E-06 |
| Normal-VS-Type2 PRCC |
2.810300E-04 |
| Normal-VS-KIRP CIMP |
1.536590E-01 |
| Normal-VS-Unclassified PRCC |
1.364700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.669000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.527800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.910400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.770800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.181200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.539000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.69869999961026E-07 |
| Normal-vs-N1 |
1.182490E-02 |
| Normal-vs-N2 |
4.914400E-01 |
| N0-vs-N1 |
1.134200E-01 |
| N0-vs-N2 |
1.179790E-01 |
| N1-vs-N2 |
5.635800E-01 |
|
|
